Hepatic ischemia-reperfusion injury (IRI) is a multifactorial phenomenon which has been
associated with adverse clinical outcomes. IRI related tissue damage is characterized by …

The severe acute respiratory syndrome coronavirus 2 or coronavirus disease 2019 (COVID-
19) pandemic has raised concerns about the correlation with this viral illness and increased …

No-reflow is responsible for 40% of the primary percutaneous coronary intervention without
complete myocardial reperfusion despite successful reopening of the infarct-related artery …

Despite efforts to restore tissue perfusion after myocardial infarction, coronary no-reflow—a
failure to achieve adequate reperfusion of the cardiac microcirculation—is a common …

Objective: Reflow following coronary artery occlusion is an important predictor of clinical
outcome. This study tests the effects of regional hypothermia, initiated late during ischemia …

Prediction of no-reflow phenomenon in patients treated with... : Medicine Prediction of no-reflow
phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment …

Reperfusion may cause intramyocardial hemorrhage (IMH) by extravasation of erythrocytes
through severely damaged endothelial walls. The purpose of the study was to evaluate the …

Myocardial infarction (MI) and its resultant heart failure remains a major cause of death in
the world. The current treatments for patients with MI are revascularization with thrombolytic …

Early coronary artery reperfusion improves outcomes for patients with ST-segment elevation
myocardial infarction (STEMI), but morbidity and mortality after STEMI remain unacceptably …

Coronary artery thrombosis, caused either by fissuring or erosion of atherosclerotic plaques,
is the usual cause of acute myocardial infarction. 1 If a coronary occlusion persists for more …